Dr. Jennifer M. Suga
Claim this profileKaiser Permanente-Oakland
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
38 reported clinical trials
103 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Jennifer M. Suga is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
More about Jennifer M. Suga
Clinical Trial Related1 year of experience running clinical trials · Led 38 trials as a Principal Investigator · 14 Active Clinical TrialsTreatments Jennifer M. Suga has experience with
- Pembrolizumab
- Carboplatin
- Atezolizumab
- Paclitaxel
- Pemetrexed
- Nivolumab
Breakdown of trials Jennifer M. Suga has run
Non-Small Cell Lung Cancer
Lung Cancer
Parotid Gland Cancer
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Jennifer M. Suga specialize in?
Is Jennifer M. Suga currently recruiting for clinical trials?
Are there any treatments that Jennifer M. Suga has studied deeply?
What is the best way to schedule an appointment with Jennifer M. Suga?
What is the office address of Jennifer M. Suga?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.